There were many personal ups and downs, as well as newsworthy cancer advancements in the year 2016. CURE covered them all. Check out our top stories from the year.
With more than 20 approvals for cancer treatments from the U.S. Food and Drug Administration (FDA) and landmark legislation signed into law that will allocate money for cancer research over the next decade, 2016 has been an exciting year in the field of oncology. For that, CURE’s community of writers and readers continued to grow this year, as we published countless online exclusives about breaking news, experts’ takes on emerging treatments, personal stories from our contributors and more.
Here are our top 10 most successful stories of 2016.
New treatments, such as immunotherapy, continueto prove successful for patients with glioblastoma, one of the most dangerous cancers.
Although patients and survivors often complain of chemo brain during and after treatment for cancer, a growing body of research shows that there are multiple causes behind the cognitive decline many survivors experience.
Treatment for the polio virus may eventually move into the treatment realm for brain cancer, thanks to a breakthrough therapy designation by the FDA.
In the oncology world, gastrointestinal cancers may be the next in line to realize the promise of immunotherapy.
It makes perfect sense to me now that exhaustion is one of the byproducts of cancer treatment. As blood counts drop, cells die, and the mental stress and strain builds, the vital energy force no longer flows like a raging river—it has all the power of a dripping faucet, says Mike Verano.
If you really break it down, there are only two emotions that consume the world and all its living beings: love and fear, writes Kate Beland.
Four new drugs, and novel treatment combinations, are further extending life expectancy for patients with multiple myeloma.
The “sugar is poison” ideology is wrong, says nutritionist and registered dietician Amanda Bontempo.
Thyroid cancer comprises approximately 4 percent of all cancers; however, the number of new diagnoses has increased substantially in recent years.
Jennifer Arnold, M.D., talks about having rare cancer alongside skeletal dysplasia, and sharing it all on national television.